CIC
BSX icon

Cornercap Investment Counsel’s Boston Scientific BSX Stock Holding History

Cornercap Investment Counsel’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-47,752
Closed -$2.03M – 554
2021
Q4 		$2.03M Buy
47,752
+547
+1% +$23K 0.29% 87
2021
Q3 		$2.05M Buy
+47,205
New +$2.09M 0.23% 106

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Cornercap Investment Counsel's BSX Position: Q1 2022 in Review

Cornercap Investment Counsel sold out of Boston Scientific (BSX) in Q1 2022, closing a stake of 47,752 shares — an estimated $2.03M sold.

Cornercap Investment Counsel first reported a position in BSX in Q3 2021 and held it in 2 quarters. The position peaked at $2.05M in Q3 2021. 904 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

  • Cornercap Investment Counsel reported no remaining Boston Scientific position as of Q1 2022 after selling out during the quarter.
  • Cornercap Investment Counsel sold 47,752 Boston Scientific shares in Q1 2022, an estimated $2.03M.
  • Cornercap Investment Counsel first reported a position in Boston Scientific in Q3 2021 and held it in 2 quarters.
  • Cornercap Investment Counsel's Boston Scientific position peaked at $2.05M in Q3 2021.
  • 904 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Cornercap Investment Counsel's 13F filing for Q1 2022, filed 10 May 2022.